Je veux savoir à propos de…

khammond on DSKJM1Z7X2PROD with RULES2

32400

Federal Register / Vol. 86, No. 116 / Monday, June 21, 2021 / Rules and Regulations
Food and Drug Administration FDA. 2020, December 11. Emergency use authorization for an unapproved product review memorandum Pfizer-BioNTech COVID19 vaccine/BNT 162b2 mRNA
1273. https www.fda.gov/emergencypreparedness-and-response/coronavirusdisease-2019-covid-19/pfizer-biontechcovid-19-vaccine. FDA, December 11, 2020.
Food and Drug Administration FDA. 2020, December 18. Emergency use authorization for an unapproved product review memorandum Moderna COVID
19 vaccine/mRNA1273. https
www.fda.gov/emergency-preparednessand-response/coronavirus-disease-2019covid-19/moderna-covid-19-vaccine.
FDA, December 18, 2020.
Food and Drug Administration FDA. 2021, February 26. Janssen COVID19
vaccine. Vaccines and Related Biological Products Advisory Committee, February 26, 2021 Meeting Briefing Document.
https www.fda.gov/media/146219/
download. FDA, February 26, 2021.
Gharpure, R et al., 2021, February 5. Early COVID19 first-dose vaccination coverage among residents and staff members of skilled nursing facilities participating in the pharmacy partnership for long-term care program United States, December 2020January 2021. MMWR 2021; 70: 178182. DOI:
http dx.doi.org/10.15585/
mmwr.mm7005e2. Gharpure et al., February 5, 2021.
Hall, VJ et al., 2021, April 23. COVID19
vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection SIREN: A prospective, multicentre, cohort study. Lancet. 2021
Apr 23: S014067362100790X. doi:
10.1016/S014067362100790X.
Online ahead of print. PMID: 33901423.
Hall et al., April 23, 2021.
Howard, J. 2021, May 22. Response to request for an assessment by the National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, of the current hazards facing healthcare workers from Coronavirus Disease2019 COVID19.
Howard, May 22, 2021.
Keehner et al., 2021, May 6. SARSCoV2
infection after vaccination in health care workers in California. New England Journal of Medicine 38418. Keehner et al., May 6, 2021.
KFF. 2021, April 22. KFF COVID19
Vaccine Monitor https www.kff.org/
coronavirus-covid-19/dashboard/kffcovid-19-vaccine-monitor-dashboard/.
KFF, April 22, 2021.
King, WC et al., 2021, April 24. COVID19
vaccine hesitancy JanuaryMarch 2021
among 1864 year old US adults by employment and occupation. medRxiv;
https www.medrxiv.org/content/
10.1101/2021.04.20.21255821v3. King et al., April 24, 2021.
Levine-Tiefenbrun, M et al., 2021, February 8. Decreased SARSCoV2 viral load following vaccination. medRxiv. 2021;

VerDate Sep<11>2014

21:53 Jun 17, 2021

Jkt 253001

https www.medrxiv.org/content/
10.1101/2021.02.06.21251283v1.full.pdf.
Levine-Tiefenbrun, February 8, 2021.
Marks, M et al., 2021, February 2.
Transmission of COVID19 in 282
clusters in Catalonia, Spain: A cohort study. Lancet Infect Dis. 215: 629636.
doi: 10.1016/S1473309920309853.
Epub 2021 Feb 2. PMID: 33545090;
PMCID: PMC7906723. Marks et al., February 2, 2021.
Pawlowski, C et al., 2021, February 27.
FDA-authorized COVID19 vaccines are effective per real-world evidence synthesized across a multi-state health system. medRxiv Preprint posted online February 27, 2021. https
www.medrxiv.org/content/10.1101/
2021.02.15.21251623v3. Pawlowski et al., February 27, 2021.
Roy, B et al., 2020, December 29. Health care workers reluctance to take the COVID19 vaccine: A consumermarketing approach to identifying and overcoming hesitancy. https
catalyst.nejm.org/doi/full/10.1056/
CAT.20.0676. Roy et al., December 29, 2020.
Schrading, WA et al., 2021, February 19.
Vaccination rates and acceptance of SARSCoV2 vaccination among U.S.
emergency department health care personnel. Acad Emerg Med 28: 455
458. Schrading et al., February 19, 2021.
Shah, ASV et al., 2021, March 21. Effect of vaccination on transmission of COVID
19: an observational study in healthcare workers and their households. medRxiv.
2021 https www.medrxiv.org/content/
10.1101/2021.03.11.21253275v1. Shah et al., March 21, 2021.
Swift, MD et al., 2021, April 26.
Effectiveness of mRNA COVID19
vaccines against SARSCoV2 infection in a cohort of healthcare personnel.
Clinical Infectious Diseases DOI: https
doi.org/10.1093/cid/ciab361. Swift et al., April 26, 2021.
Tande, AJ et al., 2021, March 10. Impact of the COVID19 Vaccine on asymptomatic infection among patients undergoing preprocedural COVID19 molecular screening. Clin Infect Dis. 2021 Mar 10:
ciab229. doi: 10.1093/cid/ciab229. Epub ahead of print. PMID: 33704435; PMCID:
PMC7989519. Tande et al., March 10, 2021.
Teran, RA et al., 2021, April 30.
Postvaccination SARSCoV2 infections among skilled nursing facility residents and staff membersChicago, Illinois, December 2020March 2021. MMWR
7017: 632638. Teran et al., April 30, 2021.
Thompson, MG et al., 2021, April 2. Interim estimates of vaccine effectiveness of BNT162b2 and mRNA1273 COVID19
vaccines in preventing SARSCoV2
infection among health care personnel, first responders, and other essential and frontline workerseight U.S. locations, December 2020March 2021. MMWR 70:
495500. DOI: http dx.doi.org/
10.15585/mmwr.mm7013e3. Thompson et al., April 2, 2021.

PO 00000

Frm 00026

Fmt 4701

Sfmt 4700

Xie, X et al., 2021, February 8.
Neutralization of SARSCoV2 spike 69/
70 deletion, E484K and N501Y variants by BNT162b2 vaccine elicited sera.
Nature Medicine. DOI: https doi.org/
10.1038/s41591-021-01270-4. Xie et al., February 8, 2021.

III. Impact on Healthcare Employees Data on SARSCoV2 infections, illnesses, and deaths among healthcare employees supports OSHAs finding that COVID19 poses a grave danger to these employees. Even fairly brief exposure i.e., 15 minutes during a 24hour period can lead to infection, which in turn can cause death or serious impairment of health. Employees in healthcare settings include healthcare employees, who provide direct patient care e.g., nurses, doctors, and emergency medical technicians EMTs, and healthcare support employees, who provide services that support the healthcare industry and may have contact with patients e.g., janitorial/
housekeeping, laundry, and food service employees. Employees who perform autopsies are also considered to work in healthcare. Most employees who work in healthcare perform duties that put them at elevated risk of exposure to SARSCoV2.
SARSCoV2 is introduced into healthcare settings by infected patients, other members of the public, or employees. Workers in healthcare settings that provide treatment to patients with suspected or confirmed COVID19 face a particularly elevated risk of contracting SARSCoV2
Howard, May 22, 2021. Once the virus is introduced into the worksite, the virus can be transmitted from person-toperson at close contact through inhalation of respiratory droplets. In limited scenarios, it might also be transmitted through inhalation of aerosols, which consists of small droplets and particles that can linger in the air, especially in enclosed spaces with inadequate ventilation CDC, May 7, 2021. Less frequently, transmission is also possible when someone touches a contaminated item or surface and then touches their nose, mouth, or eyes CDC, April 5, 2021.
A 2021 cross-sectional study of 6,510
healthcare employees from the Northwestern HCW SARSCoV2
Serology Cohort Study conducted May 28June 30, 2020 in Illinois shows that infections among healthcare workers were not limited to doctors and nurses;
healthcare administrators had similar rates of seropositivity compared to physicians, and support services had the highest seroprevalence this group included healthcare facility workers in
E:FRFM21JNR2.SGM

21JNR2